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Prevalence of Hypertension in Low- and
Middle-Income Countries
A Systematic Review and Meta-Analysis
Ahmed M. Sarki, MSc, Chidozie U. Nduka, MD, MPH, Saverio Stranges, MD, PhD,
Ngianga-Bakwin Kandala, PhD, and Olalekan A. Uthman, MD, MPH, PhD
Abstract: We aimed to obtain overall and regional estimates of
hypertension prevalence, and to examine the pattern of this disease
condition across different socio-demographic characteristics in low-and
middle-income countries.
We searched electronic databases from inception to August 2015.
We included population-based studies that reported hypertension preva-
lence using the current definition of blood pressure 140/90 mm Hg or
self-reported use of antihypertensive medication. We used random-
effects meta-analyses to pool prevalence estimates of hypertension,
overall, by World Bank region and country income group. Meta-
regression analyses were performed to explore sources of heterogeneity
across the included studies.
A total of 242 studies, comprising data on 1,494,609 adults from 45
countries, met our inclusion criteria. The overall prevalence of hyper-
tension was 32.3% (95% confidence interval [CI] 29.4–35.3), with the
Latin America and Caribbean region reporting the highest estimates
(39.1%, 95% CI 33.1–45.2). Pooled prevalence estimate was also
highest across upper middle income countries (37.8%, 95% CI 35.0–
40.6) and lowest across low-income countries (23.1%, 95% CI 20.1–
26.2). Prevalence estimates were significantly higher in the elderly (65
years) compared with younger adults (<65 years) overall and across the
geographical regions; however, there was no significant sex-difference
in hypertension prevalence (31.9% vs 30.8%, P¼ 0.6). Persons without
formal education (49.0% vs 24.9%, P< 0.00001), overweight/obese
(46.4% vs 26.3%, P< 0.00001), and urban settlers (32.7% vs 25.2%,
P¼ 0.0005) were also more likely to be hypertensive, compared with
those who were educated, normal weight, and rural settlers respectively.
This study provides contemporaryandup-to-date estimates that reflect
the significant burden of hypertension in low- and middle-income
countries, as well as evidence that hypertension remains a major public
health issue across thevarious socio-demographic subgroups.On average,
about 1 in 3 adults in the developingworld is hypertensive. The findings of
this study will be useful for the design of hypertension screening and
treatment programmes in low- and middle-income countries.
(Medicine 94(50):e1959)
Abbreviations: BMI = body mass index, CI = confidence interval,
LMICs = low- and middle-income countries, MeSH = Medical
Subject Heading, mm Hg = millimetres of mercury, PRISMA =
Preferred Reporting Items for Systematic Reviews and Meta-
analyses, WHO = World Health Organization.
INTRODUCTION
H ypertension drives the global burden of cardiovasculardisease, being widely acknowledged as the most common
cardiovascular disorder and number 1 risk factor formortality.1–3
The occurrence of hypertension is increasing globally, with
projections estimating a 30% increase in prevalence by the year
2025.4 However, owing to several factors such as the ongoing
nutritional transition, increasing trends in sedentary lifestyle, and
othermodifiable risk factors, and inadequate health care systems,
populations in low- and middle-income countries (LMICs) may
bear a higher burden of the disease, compared with the global
average. Projections estimate that three-quarters of the world’s
hypertensive population will reside in LMICs within the next
decade.4 However, there is a dearth of evidence providing up-to-
date estimates of the occurrence of hypertension and its deter-
minants across the developing regions of the world. The existing
systematic reviews have, hitherto, been country-specific,5 or
focused on African populations.6,7 Therefore, we aimed to fill
this gap in the evidence by providing overall and regional
estimates of hypertension prevalence across LMICs and to
examine the pattern of this disease across different socio-demo-
graphic characteristics.
METHODS
Protocol and Registration
The systematic review rational and methods were specified
in advance and documented in a protocol, which was published
in the PROSPERO register (CRD42013006162).8
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Eligibility Criteria
We included population-based studies that reported crude
prevalence estimates of hypertension in LMICs (see Table 1 for
full inclusion and exclusion criteria).
Information Sources and Search Strategy
We searched the following electronic databases from
inception to August 2015: EMBASE, Ovid MEDLINE, and
the WHO Global Cardiovascular Infobase for relevant articles.
The search was conducted using the following medical subject
heading (MeSH) terms and keywords: ‘‘hypertension’’ OR
‘‘blood pressure’’ OR ‘‘hypertens

’’ AND ‘‘population-based’’
OR ‘‘etiology’’ OR ‘‘etiology’’ OR ‘‘prevalence’’ OR
‘‘epidemiolog

’’ AND ‘‘low- and middle-income countries’’
OR ‘‘developing countries’’ (see Appendix 1 for the MEDLINE
search strategy, http://links.lww.com/MD/A543). We also
scanned through cross-references of identified primary studies
and review articles for eligible studies.
Study Selection
Three reviewers (AMS, CN, and OU) independently eval-
uated the eligibility of the studies obtained from the literature
searches. All articles yielded by the database search were
initially screened by their titles and abstracts to obtain studies
that met our inclusion criteria. In cases of discrepancies,
agreement was reached by consensus and by discussion with
a fourth reviewer (SS).
Data Collection Process and Data Items
Three reviewers (AMS, CN, and OU) independently eval-
uated the methodological quality of each included study and
extracted data using a piloted form; discrepancies were resolved
by discussion with a fourth reviewer (SS). Data extracted
included year of publication, country of origin, study design,
sample size, sampling strategy, study period, setting (rural/
urban), gender distribution, age group, mean age, body mass
index (BMI) category, hypertension prevalence, diagnostic
criteria for hypertension, confounders, smoking status, alcohol
use, education and employment status. Countries were grouped
by region and income according to World Bank9 development
indicators. Age group, gender, BMI category, smoker status,
alcohol use, and study setting were coded as dichotomous
variables. We defined overweight/obesity as BMI  25kg/m2.
Total prevalence estimates of hypertension were calculated from
studies providing only subgroup estimates. The total mean age in
each studywas alsoobtained fromreports of this variablemeasure
within subgroups.
Risk of Bias in Included Studies
Methodological quality entailed assessing the risk of bias
for each study using a domain-based tool adapted from the
Newcastle-Ottawa Scale (see Appendix 2, http://links.lww.com/
MD/A543).10 The risk of bias in each study was classified as
low, moderate, high or unclear across the following domains:
selection of participants (selection bias), sample size justifica-
tion (selection bias), outcome measurement (detection bias),
and confounding adjustment.
Ethical Approval
Being a systematic review of published literature, no
ethical approval was required for conducting this study. How-
ever, we ensured that all studies included in our review provided
evidence of ethical approval and informed consent from all
patients or respondents where required.
Statistical Analysis
We stabilized the raw proportions of participants with
hypertension from each study using the Freeman–Tukey variant
of the arcsine square root transformed proportion11 suitable for
pooling proportions (see Appendix 3, http://links.lww.com/MD/
A543). In performing the meta-analyses, we used the DerSi-
monian–Laird random-effects model12 due to anticipated vari-
ations in study population, methodologies, and stage of
epidemic transition. We assessed heterogeneity among studies
by inspecting the forest plots and using the chi squared test for
heterogeneity with a 10% level of statistical significance, and
using the I2 statistic, where we interpreted a value of 50% as
representing moderate heterogeneity.13,14 We assessed the
potential for publication bias by evaluating funnel plot asym-
metry using Egger’s test for regression asymmetry.15 Where
there was evidence of publication bias, we used the ‘‘trim and
fill’’ analysis of Duval and Tweedie16 to examine the potential
impact of missed or unpublished studies on the pooled estimates
of hypertension prevalence.
The potential modifying effects of various study-level
variables on the overall prevalence of hypertension were
TABLE 1. Eligibility criteria
Inclusion Exclusion
Population Adults (18 years and above) Adolescents and children
Outcome Hypertension prevalence reported or deducible
from subgroup estimates
Hypertension prevalence not reported
Hypertension assessed as: Pulmonary hypertension
BP  140/90mm Hg, Hypertension assessed as:
use of antihypertensive drugs, BP  160/95mm Hg or other assessment criteria
self-reported physician-diagnosed cases
Study All population-based studies, regardless of the design: Hospital-based studies
cross-sectional studies, Policy reports
cohort studies, Expert reviews
randomized controlled trials Studies not published in English language
Studies published in English language
Study location Low- and middle-income countries High-income countries
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explored using subgroup and univariable random-effects meta-
regression analyses: year of publication, age group, gender,
education status, employment status, smoker status, alcohol use,
overweight/obesity, country income groups,9 and study settings
(urban, rural or mixed).
Hypertension prevalence estimates were reported with
95% confidence intervals (CIs). All P values were exact (except
where P< 0.0001)14 and 2-tailed; P< 0.05 was considered
statistically significant. Analyses were conducted using Stata
version 12 forWindows (Stata Corp, College Station, TX) using
the ‘‘metaprop’’ rountine.17 This systematic review was
reported according to the Preferred Reporting Items for Sys-
tematic Reviews and Meta-analyses (PRISMA) guidelines
(http://www.prisma-statement.org).18 The PRISMA checklist
is provided in Appendix 4, http://links.lww.com/MD/A543.
RESULTS
Study Flow and Characteristics
Figure 1 shows the study selection flow. The literature
search yielded 3315 articles. After an initial screening process,
404 articles were selected for critical reading. One hundred and
sixty two (162) studies were excluded for not meeting the
selection criteria, leaving 242 studies (from 239 publi-
cations),19–254 which we considered eligible for inclusion in
this systematic review. Table 2 and eTables 1–6, http://links.
lww.com/MD/A543 summarize the characteristics of the
included studies by region.
Studies comprised data on 1,494,609 participants (52%
females) from 45 countries (Table S7, http://links.lww.com/
MD/A543). Most of the studies were conducted in India (n¼ 50
studies; 20.7%), Brazil (n¼ 26; 10.7%), Nigeria (n¼ 25;
10.3%), and China (n¼ 22; 9.1%). Although a third of the
included studies (n¼ 74; 30.6%) originated from sub-Saharan
African countries, all 6 regions, including East Asia and Pacific,
Europe and Central Asia, Latin America and Caribbean, Middle
East and North Africa, South Asia, and sub-Saharan Africa were
represented in our review. Figure 2 showcases country-wide
differences among the 45 countries included in this study.
All articles were population-based observational studies.
Hypertension was diagnosed as blood pressure (BP) 140/90
mm Hg in all but 3 studies where assessment was based on self-
reported physician diagnoses alone.58,62,70 The mean age over-
all was 45.9 12.1 years with participants from Europe and
Central Asia being the youngest (35.7 11.4 years) and those
from East Asia and Pacific being the oldest (51.7 9.1 years).
Participants in the Middle East and North Africa had the highest
estimates of combined overweight/obesity (56.8% [95% CI
40.6–73.2]), whereas the lowest rates were found in the South
Asia region (29.0% [95% CI 18.4–41.0]).
FIGURE 1. PRISMA flow diagram showing study selection.
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Risk of Bias of Included Studies
Summary of risk of bias assessment for each study is
shown in Appendix 5, http://links.lww.com/MD/A543. Overall,
111 studies (46%) were assessed as having low risk of selection
bias within the sampling domain, having selected participants
randomly. Based on sample size justification, the risk of
selection bias was also assessed as low in 73 studies (30%).
Detection bias was low in 193 studies (80%) reporting the use of
a validated tool for measuring blood pressure. However, assess-
ment of hypertension was not blind in any of the included
studies, consequently resulting in high risk of detection bias
within this domain in all 242 studies.
Pooled Prevalence by Geographical Regions
The country-specific prevalence of hypertension is shown in
Figure 2. All 242 studies reported the crude prevalence of
hypertension and were included in meta-analysis. The reported
hypertension ranged from 2.5% (95% CI 1.9–3.2)107 to 90%
(95% CI 89.9–90.2)29 (both studies in India). The pooled hyper-
tension prevalence for all studies yielded an estimate of 32.3%
(95% CI 29.4–35.3). The I2 statistic was 99.9%, indicating
substantial heterogeneity across the included studies. The
contour-enhanced funnel plot for assessing publication bias
is shown in eFigure 1, http://links.lww.com/MD/A543. The
funnel plot appears symmetric and shows no evidence of
publication bias.
The prevalence estimates of hypertension across regions,
country income groups, and settings are shown in Figure 3.
Subgroup analysis by region showed the highest prevalence
estimate of hypertension in the Latin America and Caribbean
region (39.1% [95% CI 33.1–45.2]) (eFigure 2, http://links.lww.
com/MD/A543)29,35,46–73 whereas the Middle East and North
Africa region had the lowest prevalence (26.9% [95% CI 19.3–
35.3]) (eFigure 3, http://links.lww.com/MD/A543).74–81
The East Asia and Pacific region (35.7% [95% CI 32.2–
39.4]) (eFigure 4, http://links.lww.com/MD/A543)19–37 and
Europe and Central Asian region (32.0% [95% CI 28.0–
37.0]) were second and third respectively to the Americas
(eFigure 4, http://links.lww.com/MD/A543 and eFigure 5,
http://links.lww.com/MD/A543). Prevalence estimates for the
Sub-Saharan Africa38–45 and South Asia29,35,82–108 regions are
shown respectively in eFigure 6, http://links.lww.com/MD/
A543 and eFigure 7, http://links.lww.com/MD/A543.
Pooled Prevalence by Country Income Groups
Upper middle income countries had a higher prevalence of
hypertension (37.8% [95%CI 35.0–40.6]), compared with lower
middle income (31.1% [95% CI 26.1–36.4]) and low-income
countries (23.1% [95% CI 20.1–26.2]) (eFigures 8–10, http://
links.lww.com/MD/A543). Hypertension prevalence was also
higher among populations in urban settings (32.7% [95% CI
30.4–35.0]), compared with populations in rural settings (25.2%
[95% CI 20.9–29.8]) (eFigures 11 and 12, http://links.lww.com/
MD/A543).29–31,40,42,76,78,80,99,111,113,121,128,131, 135,136,140,146
Pooled Prevalence by Participants’
Socio-Demographic Characteristics
We summarized the patterns of hypertension across differ-
ent socio-demographic characteristics for each region in Table 3.
In all regions except the Middle East and North Africa region,
where no data on hypertension prevalence was reported
for the elderly (65 years), the proportion of hypertension
was substantially higher among adults  65 years, compared toTA
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adults < 65 years (mean prevalence 65.6% [95% CI 53.6–75.0]
vs 28.7% [95% CI 21.8–37.6], P< 0.00001).22,23,30,31,40,42,46,55,
56,59,61,62,65,66,69,70,84,90,91,95,97,99,101,113,117,121,122,128,131,134–136,
146,147 Nonetheless, hypertension prevalence in the Middle
East and North Africa region was reportedly high among adults
< 65 years (32.4% [95% CI 18.7–47.9]).78,79
Although prevalence of hypertension in men overall (33%)
was slightly higher compared with women (31.2%), this differ-
ence was not statistically significant (P¼ 0.76). Additionally,
no significant sex-deference in hypertension prevalence was
observed by region.
We found higher proportions of hypertension among non-
smokers compared to smokers in Europe and Central Asia,
Latin America and Caribbean, and Middle East and North
Africa regions. Whereas the proportions of hypertension was
higher amongst smokers compared to nonsmokers in East Asia
and Pacific, South Asia, and Sub-Saharan Africa regions.
Alcohol use data was not reported in any study originating
from countries in the Middle East and North Africa or the East
Asia and Pacific regions. With the exception of the sub-Saharan
Africa region, hypertension rates were comparable between
nondrinkers and current drinkers; nondrinkers had a substan-
tially higher proportion of hypertension compared to current
drinkers in sub-Saharan Africa (32.0% [95% CI 20.9–44.2] vs
21.7% [95% CI 14.6–29.6], P< 0.00001).113,121,131,135,136,140
Importantly, hypertension rates were consistently higher among
overweight/obese participants, compared to normal weight
persons across all regions (mean prevalence 46.4% [95% CI
FIGURE 2. Prevalence estimates of hypertension by region, income group, and study setting.
Medicine  Volume 94, Number 50, December 2015 Burden of Hypertension in Resource-Limited Settings
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved. www.md-journal.com | 5
33.1–60.7] vs 26.3% [95%CI 15.8–37.8],P< 0.00001).30,33,41,
44,47,55,56,61,62,65,66,69,78,85,90,97,99,106,113,117,128,131,134–136,140
With respect to study setting, prevalence estimates of
hypertension were higher in urban communities, compared to
participants in rural settings in the Latin America and Caribbean
region (51.2% [95% CI 30.1–72.0] vs 42.8% [95% CI 26.1–
60.4], P¼ 0.00017),29 East Asia and Pacific (51.2% [32.8–
69.5] vs 47.5% [25.5–70.1], P< 0.00001), South Asia (35.9%
[95% CI 19.1–54.7] vs 28.0% [95% CI 18.8–38.2],
P< 0.00001),29,99 and Sub-Saharan Africa (34.9% [95%
CI 23.0–47.8] vs 29.9% [95% CI 22.6–37.9], P¼ 0.017).111,
113,121,128,131,135,136,140,146
Hypertension rates were also generally higher among the
noneducated, compared to participants with a primary education
(mean prevalence 50.2% [95%CI 30.4 – 69.3] vs 36.3% [95%CI
23.7–50.4], P< 0.00001) and participants with a secondary or
tertiary education (mean prevalence 25.0% [95%CI 18.8 – 31.9],
P< 0.00001).22,30,31,33,40,41,44,47,55,56,61,65,66,69,70,76,79,81,97,99,
106,113,117,121,128,131,134,136,140,146,147
Factors Associated With the Overall
Hypertension Prevalence
The results of the meta-regression analyses showed that
age (coefficientþ 0.04 [95% CI 0.03–0.05], P< 0.0001)
(Fig. 4), overweight/obesity (coefficientþ 0.02 [95% CI
0.01–0.03] P¼ 0.001) (Fig. 5), and educational status
(coefficientþ 0.01 [95% CI 0.001–0.02] P¼ 0.049) (Fig. 6)
accounted for significant heterogeneity in hypertension preva-
lence between studies. Given that<50% of the included studies
had a low risk of sampling bias, we performed meta-regression
analysis to determine if the observed heterogeneity in hyper-
tension prevalence was partly influenced by variations in
population sampling between studies; our analysis showed no
statistically significant effect (coefficientþ 0.11 [95% CI
0.04–0.26], P¼ 0.14).
DISCUSSION
Main Findings
To our knowledge, this is the first systematic review on
hypertension prevalence and its socio-demographic patterning
in the developing world. Our review suggests that hypertension
remains an important public health problem in LMICs, with 1 in
3 persons affected by the disease. Our findings also suggest that
older age and increased body weight may be consistent pre-
dictors of hypertension across LMICs, given that prevalence
estimates of hypertension were substantially higher in the
elderly, compared with younger adults, and in overweight/obese
persons, compared with normal weight persons. Lower edu-
cational status was also found to be associated with a high
FIGURE 3. Country-specific hypertension prevalence.
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prevalence of hypertension; however, this association was not
consistent across counties and geographical regions.
Our results correspond to Kearney and colleagues4 who
found hypertension prevalence to be highest among Latin
America and Caribbean populations, compared to other regions,
based on data collected prior to 2001. This broadly suggests that
hypertension prevalence estimates in the Latin America and
Caribbean region may have driven the burden of the disease in
the developing world for more than a decade. Hypertension rates
were more likely to be higher in upper middle income countries
than in lower middle income countries, and the latter more likely
to be higher compared to low-income countries. We hypothesize
that a temporal relationship exists between increasing levels of
affluence and urbanization and raised blood pressure. This
plausibly accounts for the graded rise in hypertension rates,
which is characteristic of the epidemiological transition within
urban societies in resource-limited settings.241,242 The higher
prevalence of hypertension in urban settings compared to rural
settings, as shown in our study and in previous reviews,6,243 are
also in accordance with this hypothesis.
Our findings also suggest that hypertension may be associ-
ated with socio-economic inequalities in LMICs: prevalence
estimates for hypertension were inversely proportional to edu-
cational attainment, resulting in a downward socioeconomic
gradient for hypertension. Evidence of health inequalities associ-
ated with hypertension in LMICs are not uncommon.244,245
Although men and women hypertension prevalence estimates
were comparable overall, the slightly higher prevalence in
men than women observed in our results are consistent with
previous systematic reviews.6,243 This slight difference may be
explained by evidence confirming male predilection for cardio-
vascular problems in the middle-age group, which attenuates in
older adults as exemplified by an increased risk of cardiovascular
diseases among post-menopausal women.244,245 Nonetheless, we
observed a significant direct association between mean age and
hypertension prevalence, which may be attributed to age-related
structural changes in blood vessels which potentially cause
narrowing of the vascular lumen, and consequently increasing
blood pressure, as have been reported in previous studies.246–248
This hypothesis may also explain the unusually high prevalence
estimates of hypertension (> 70%) observed in a few of the
included studies,30,32,232 given that the sampled population in
these studies comprised mostly of the elderly.
Our review confirms that smoking is an independent risk
factor for hypertension in Asian communities,249,250 given that
smokers were more likely than nonsmokers to be hypertensive
in the Asia regions alone.
Nevertheless, the higher proportions of hypertension
among nonsmokers compared to smokers in the non-Asia
regions may be attributed to smokers erroneously self-reporting
their smoker status as nonsmokers in some of the included
studies. Whereas this argument may account for the higher
prevalence of hypertension among nondrinkers, compared to
drinkers, in the sub-Saharan Africa region, it is also important to
emphasize that nonsmokers and nondrinkers alike may engage
in other harmful behaviors known to increase the risk of
hypertension. Obviously, we cannot rule out the potential of
reverse causation in cross-sectional studies, as it is possible that
both nonsmokers and nondrinkers may have quit these harmful
behaviors due to underlying medical conditions.251 However, it
is important to state that we were not able to separate never
smokers and never drinkers from exsmokers and exdrinkers in
most of the included studies.
The association between combined overweight/obesity
and hypertension shown in our results exemplify the role of
excess body weight in hypertension prevalence, which has been
long recognized and consistent across numerous observational
and trial data.252–256
FIGURE 4. Meta-regression of hypertension against age.
FIGURE 5. Meta-regression of hypertension prevalence against
overweight/obesity.
FIGURE 6. Meta-regression of hypertension against education.
Sarki et al Medicine  Volume 94, Number 50, December 2015
8 | www.md-journal.com Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
Study Limitations and Strengths
We acknowledge that the overall quality of the included
studies was moderate at best, especially given that more than a
third of the studies (39%) were assessed as having high risk of
sampling bias. However, as shown using meta-regression
analysis, we emphasize that the high rates of sampling bias
had no undue impact on the overall hypertension prevalence.
High amounts of heterogeneity across the included studies
were another limitation of our study. Prevalence estimates from
different regions were pooled in this meta-analysis, and as
expected, high heterogeneity between studies was found in the
meta-analyses. A substantial amount of the heterogeneity across
studies was explained by such factors as differences in population
characteristics and study methodologies. Nonetheless, as
affirmed by previous evidence, meta-analyses are the preferred
options to narrative syntheses for interpreting the results in a
review, even in spite of the presence of a considerable amount of
heterogeneity.257 Heterogeneity appeared to be the norm rather
than exception in published meta-analyses of observational
studies, in which case, it should be expected and quantified
appropriately.258 Although we found some evidence of publi-
cation bias, it has been documented that tests of publication bias
may lead to false-positive results in the presence of significant
heterogeneity.257,259 Nonetheless, the ‘‘trim and fill’’ analysis
revealed that the presence of publication bias had no significant
impact on the overall prevalence of hypertension. Although we
might have missed some potentially relevant studies; however,
this systematic review arguably constitutes the largest study on
hypertension prevalence in the resource-limited settings, com-
prising >1 million participants. In addition, we speculate that
nonsmokers and nondrinkers may potentially be at risk of
hypertension due to other health-damaging behaviors; our study
therefore highlights the importance of expatiating on other
lifestyle variables as potential correlates of hypertension and
other cardiovascular conditions. For example, we were not able to
examine the potential impact of differential dietary patterns and
dietary salt intake on the observed variations in hypertension
prevalence across countries. It is likely that differences in average
dietary salt intake at the population level may contribute to some
of the observed variations in hypertension prevalence across
countries and world regions.259–261
In spite of the aforementioned limitations, the review’s
strengths are important. We conducted comprehensive searches
of databases to ensure that all relevant publications were
identified. We also reduced potential bias in the conduct of
this review by having the authors independently scan through
the search output and extract the data. In addition, there was
reasonable coverage of evidence for most geographic regions,
such as South Asia and sub-Saharan Africa; these regions were
well represented by a sufficient number of studies with large
sample size, which allows for generalizability of the results
across these geographic regions.
Implications of the Results
The elderly, overweight/obese, noneducated and urban
settlers present opportunities for targeted health promotion
and preventive interventions in LMICs. Given the high burden
of infectious diseases in these countries, it might be economi-
cally justified to implement intervention programs for hyper-
tension in higher-risk populations alone. However, the
occurrence of hypertension in the general population remains
unacceptably high, which poses an ethical dilemma to relying
on high-risk strategies only in these settings; countries in the
Middle East and North Africa region may even not have
sufficient evidence to implement public health interventions
in certain high-risk populations such as the elderly.
Health inequalities associated with hypertension have been
recognized as an important public health issue in low- and
middle-income countries.244,245,262 Addressing the wider social
determinants of the disease is therefore crucial to its control in
these countries. Failure to address these issues portends
additional threats to the sustainability of public health infra-
structure, especially alongside the prevailing effects of infec-
tious disease epidemics.
Population-wide strategies such as reduction in dietary salt
intake from processed foods are warranted in these low-
resource settings, because they have been proven to be cost-
effective means to shift blood pressure distribution at the
population level, thus reducing the burden of cardiovascular
disease associated with the epidemic of hypertension.263–268
Specifically, population-wide salt reduction through legislation,
voluntary agreements with food industries and mass media
campaigns are evidence-based cost-effective strategies for
reducing hypertension prevalence in low- and middle-income
countries, potentially preventing millions of years lost to the
disease as a result of ill-health, disability or premature death.269
The absence of studies targeting the elderly in the Middle East
and North Africa region also emphasizes the need for further
research into resident high-risk subgroups. Hypertension among
the elderly is likely to be a significant public health problem in
the region considering that prevalence estimates in the young
and middle-age are also high.
In conclusion, this study provides contemporary and up-to-
date estimates that reflect the significant burden of hypertension
and evidence that hypertension remains a major public health
issue in LMICs. On average, about one-third of the adult
population in these countries are hypertensive. However, this
evidence originates from studies limited by high risk of selec-
tion bias and substantial between-study variations in the results.
Nonetheless, we provide the most comprehensive evidence and
first pooled analyses on hypertension prevalence in the devel-
oping world. There is a need for studies to accurately predict
future trends of hypertension prevalence estimates in low- and
middle-income countries. Additionally, future studies should
explore alternative techniques to address heterogeneity, such as
disease mapping or hierarchical modeling. The findings of this
study would be useful for the design of hypertension screening
and treatment programs in LMICs.
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